longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Sotera Health

SHC

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 32.63, within the reasonable range, cheaper than 73.75% of the time in the past 5 years, and the industry ranks 5/59, the industry Median -1.52.

32.63xP/E
$18.69Stock price
$0.57Earnings per share
32.63xP/E
Stock price$18.69Earnings per share$0.57

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
53.61x
Typical range
13.93x–105.66x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific
34.95x13.43%$243.49B
DHRUSDanaher
38.82x17.40%$155.42B
AUSAgilent Tech
32.75x12.34%$47.16B
IQVUSIQVIA
32.33x0.96%$44.46B
MTDUSMettler Toledo
32.98x10.40%$29.87B
WXXWYUSWuXi Biologics
38.32x--$27.60B
MEDPUSMedpace
35.79x15.09%$17.59B
QGENUSQiagen NV
22.04x0.70%$9.02B
STVNUSStevanato Group SpA
37.93x8.92%$5.93B
SHCUSSotera Health
32.63x154.32%$5.33B
BLFSUSBioLife Solutions
32.11x1,266.67%$1.86B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.